Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis

Journal of Periodontology

Volumn 79, Issue 10, 2008, Pages 1894-1903

  Guentsch, Arndt ^a   Jentsch, Holger ^b   Pfister, Wolfgang ^c   Hoffmann, Thomas ^d   Eick, Sigrun ^c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c Institute of Medical Microbiology

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Dental scaling; Doxycycline; Moxifloxacin; Periodontitis; Root planing

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE; HETEROCYCLIC COMPOUND; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MOXIFLOXACIN; PEROXIDASE; QUINOLINE DERIVATIVE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ARTICLE; BACTERIAL COUNT; BACTEROIDES; CHRONIC PERIODONTITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVENTIVE DENTISTRY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREPONEMA DENTICOLA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTEROIDES; CHRONIC PERIODONTITIS; COLONY COUNT, MICROBIAL; COMBINED MODALITY THERAPY; DENTAL SCALING; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; GINGIVAL HEMORRHAGE; HUMANS; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PEROXIDASE; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDIES; QUINOLINES; ROOT PLANING; TREATMENT OUTCOME; TREPONEMA DENTICOLA;

EID: 53549131250     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070493     Document Type: Article

References (45)

1. Genco R, Kornman K, Williams R. Consensus report. Periodontal diseases: Pathogenesis and microbial factors. Ann Periodontol 1996;1:926-932.
2. Garant P. Phagocytic cells. In: Oral Cells and Tissues. Chicago: Quintessence Publishing; 2003:385-418.
3. Magnusson I, Low SB, McArthur WP, et al. Treatment of subjects with refractory periodontal disease. J Clin Periodontol 1994;21:628-637.
4. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8:115-181.
5. Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002;29(Suppl. 3):136-159.
6. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol 2002;73:1188-1196.
7. Al-Haroni M, Skaug N, Al-Hebshi N. Prevalence of subgingival bacteria resistant to aminopenicillins and metronidazole in dental patients from Yemen and Norway. Int J Antimicrob Agents 2006;27:217-223.
8. Villedieu A, Diaz-Torres M, Hunt N, et al. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother 2003;47:878-882.
9. Van Bambeke F, Michot J, Van Eldere J, Tulkens P. Quinolones in 2005: An update. Clin Microbiol Infect 2005;11:256-280.
10. Speciale A, Musumeci R, Blandino G, Milazzo I, Caccamo F, Nicoletti G. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. Int J Antimicrob Agents 2002;19:111-118.
11. Sobottka I, Cachovan G, Sturenburg E, et al. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 2002;46:4019-4021.
12. Eick S, Seltmann T, Pfister W. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - An in vitro study. J Clin Periodontol 2004;31:376-383.
13. Eick S, Pfister W. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: An in vitro study. J Periodontol 2004;75:1327-1334.
14. O'Leary T, Drake R, Naylor J. The plaque control record. J Periodontol 1972;43:38.
15. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996;11:266-273.
16. Tran S, Rudney J. Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. J Clin Microbiol 1999;37:3504-3508.
17. Nakajima K, Powers J, Ashe B, Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem 1979;254:4027-4032.
18. Davies B, Edwards S. Inhibition of myeloperoxidase by salicylhydroxamic acid. Biochem J 1989;258:801-806.
19. Feres M, Haffajee AD, Goncalves C, et al. Systemic doxycycline administration in the treatment of periodontal infections (II). Effect on antibiotic resistance of subgingival species. J Clin Periodontol 1999;26:784-792.
20. Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol 1998;69:772-776.
21. Akalin FA, Baltacioglu E, Sengun D, et al. A comparative evaluation of the clinical effects of systemic and local doxycycline in the treatment of chronic periodontitis. J Oral Sci 2004;46:25-35.
22. Muller HP, Holderrieth S, Burkhardt U, Hoffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol 2002;29:736-742.
23. Lindhe J, Liljenberg B, Adielsson B, Börjesson I. Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol 1983;10:100-112.
24. Listgarten M, Lindhe J, Helldén L. Effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol 1978;5:246-271.
25. Mandell RL, Socransky SS. Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis. J Periodontol 1988;59:373-379.
26. Aitken S, Birek P, Kulkarni GV, Lee WL, McCulloch CA. Serial doxycycline and metronidazole in prevention of recurrent periodontitis in high-risk patients. J Periodontol 1992;63:87-92.
27. Lundstrom A, Johansson L, Hamp S. Effect of combined systemic antimicrobial therapy and mechanical plaque control in patients with recurrent periodontal disease. J Clin Periodontol 1984;11:321-330.
28. McCulloch CA, Birek P, Overall C, Aitken S, Lee W, Kulkarni G. Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high-risk patients: Antimicrobial activity and collagenase inhibition. J Clin Periodontol 1990;17:616-622.
29. Grossi S, Skrepcinski F, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997;68:713-719.
30. Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J Clin Periodontol 2006;33:254-264.
31. Rooney J, Wade WG, Sprague SV, Newcombe RG, Addy M. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined. A placebo controlled study. J Clin Periodontol 2002;29:342-350.
32. Winkel EG, Van Winkelhoff AJ, Timmermann MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol 2001;28:296-305.
33. Greenberg RN. Overview of patient compliance with medication. Clin Ther 1984;6:592-599.
34. Fujise O, Hamachi T, Inoue K, Miura M, Maeda K. Microbiological markers for prediction and assessment of treatment outcome following non-surgical periodontal therapy. J Periodontol 2002;73:1253-1259.
35. Cugini MA, Haffajee AD, Smith C, Kent RL Jr., Socransky SS. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol 2000;27:30-36.
36. Kornman K, Karl E. The effect of long-term low-dose tetracycline therapy on subgingival microflora in refractory adult periodontitis. J Periodontol 1982;53:604-610.
37. Palmer RM, Watts T, Wilson R. A double-blind trial of tetracycline in the management of early onset periodontitis. J Clin Periodontol 1996;23:670-674.
38. Pavicic M, Van Winkelhoff AJ, Douque N, Steures R, de Graaff J. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans-associated periodontitis. A 2-year evaluation. J Clin Periodontol 1994;21:107-112.
39. Chaves ES, Jeffcoat MK, Ryerson CC, Snyder B. Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy. J Clin Periodontol 2000;27:897-903.
40. Weiss T, Shalit I, Blau H, et al. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: Inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 2004;48:1974-1982.
41. Jin L, Soder B, Corbet EF. Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis. J Periodontol 2000;71:929-939.
42. Wei PF, Ho KY, Ho YP, Wu YM, Yang YH, Tsai CC. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1β in gingival crevicular fluid: Implications for oxidative stress in human periodontal diseases. J Periodontal Res 2004;39:287-293.
43. Yamalik N, Caglayan F, Kilinc K, Kilinc A, Tumer C. The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status. J Periodontol 2000;71:460-467.
44. Dalhoff A. Immunomodulatory activities of fluoroquinolones. Infection 2005;33(Suppl. 2):55-70.
45. Cacchillo D, Walters JD. Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes. Antimicrob Agents Chemother 2002;46:1980-1984.